Austco Healthcare Ltd · ASX:AHC
Austco Healthcare — Investor Presentation (September 2021)
25 slides from Austco Healthcare's investor presentation, September 2021
Slide 1: Investor Presentation September 2021
Investor Presentation September 2021 Clayton Astles Brendan Maher CEO CFO
Slide 2: Agenda
Agenda Austco Healthcare Limited 1 Strategic Objectives 2 Market and Products 3 Financial Performance 4 Appendices 2
Slide 3: Strategic Objectives
3 Austco Healthcare Limited Strategic Objectives
Slide 4: FY22 Strategic Plan: Revenue Strategies
FY22 Strategic Plan: Revenue Strategies OBJECTIVE S T R AT E G Y Recruit more sales professionals, focus on USA, UK, Asia and Australia Austco Healthcare Limited Drive organic revenue growth Add additional resellers in new and existing markets Target national accounts in all regions Target feature r
Slide 5: FY22 Strategic Plan: Operational Strategies
FY22 Strategic Plan: Operational Strategies OBJECTIVE S T R AT E G Y Transition global distribution from Hong Kong to Malaysia Improve margins Austco Healthcare Limited Increase software and SMA sales revenue Establish strategic partnerships with market leading health technology Build brand awarenes
Slide 6: Outlook
Outlook Modern and extensible operating platform Austco Healthcare Limited Market-leading products through sustained R&D commitment COVID uncertainties exist, offset by large Order Book Rapidly growing global marketplace, expected to grow even larger post COVID Investment in Sales and Marketing reso
Slide 7: Impact of COVID-19
COVID-19 Impact of COVID-19 COVID-19 continues to impact Austco Healthcare. Whilst regions have been impacted to varying degrees, the recent lockdowns in Australia and New Zealand highlight this is an ongoing issue for us to manage. Production Access to sites • Whilst the majority of our suppliers h
Slide 8: Market and Products
8 Austco Healthcare Limited Market and Products
Slide 9: Real-time health
Real-time health Data from all systems shared Nurse Call EMR / EHR Any system which may exchange data about a Austco Healthcare Limited patient or their care RTLS ADT Initially for reporting, eventually for automation and machine learning Medical Devices Bed Flow Used to achieve More information at
Slide 10: Built-in RTLS
Built-in RTLS Real-time location has become a critical component to facilities due to its actionable data and Austco Healthcare Limited efficiencies gained through automation. Uses existing nurse call infrastructure for a cost-effective solution Data and events drive automated processes Robust repor
Slide 11: New Master Station
New Master Station Component shortage has affected our older stations Replacement is Android-based device Austco Healthcare Limited Built by Avaya, audio specialists Manages alarms Communications hub Workflow capable Standardising on Android means less work, easier maintenance 11
Slide 12: New LCD-Based Annunciator
New LCD-Based Annunciator Austco Healthcare Limited Display non-western characters Flexible application Customisable messages Customer branding 12
Slide 13: New Patient Station
New Patient Station Austco Healthcare Limited Cost-effective room controller Multiple configurations VOIP Audio Acute- and aged-care Built-in RTLS Enterprise ready 13
Slide 14: Pulse Mobile
Pulse Mobile Trend towards “Care Communications & Collaboration” apps Austco Healthcare Limited Secure text and freeform VOIP calls Task lists / reminders Assignments Rounding Advanced workflow Native nurse call system control 14
Slide 15: Financial Performance
15 Austco Healthcare Limited Financial Performance
Slide 16: FY21 Financial Snapshot
FY21 Financial Snapshot REVENUE SOFTWARE & SMA REVENUE MARGIN $31.3M 14.2% of revenue 53.5% Austco Healthcare Limited ($0.3M) or (1%) on pcp 1.3% points on pcp 1.5% points on pcp EBITDA NPAT NET CASH $5.0M $3.4M $7.8M $1.3M or 37% on pcp $0.9M or 37% on pcp $1.4M on pcp 16
Slide 17: Revenue from customers
Revenue from customers Revenue from customers were $31.3m for the year. Despite continued Revenue from customers COVID-19 restrictions impacting our ability to get on site to install, we saw a 25% increase in 2H revenue to $17.3m. 17,345 Austco Healthcare Limited • Equipment revenue was up $1.3m or
Slide 18: Gross Profit + Margin
Gross Profit + Margin Gross margin % in FY21 increased in 2H to 55.2% – a pleasing result given the 55.2% COVID-19 related supply chain cost increases. Contributing to this were: 52.7% 51.4% 51.4% 9,567 • Part way through the year we reached a strategic milestone, being the complete outsourcing of t
Slide 19: Earnings
Earnings R EP O RT ED N PAT 2,597 Statutory NPAT is $3.4 million for FY21 compared to $2.5 million for FY20. Austco Healthcare Limited The second half NPAT of $2.6 million drove the full-year result as we benefited from a rebound in revenues, particularly in the 1,695 last quarter. Included in the p
Slide 20: Cash + Debt
Cash + Debt Debt Cash • Cash on hand remains strong at $7.8m 7,770 • The majority of the proceeds from the December 2019 capital 6,447 6,340 raising have not yet been deployed on the proposed Sales 6,061 Austco Healthcare Limited initiatives given the interruptions caused by COVID-19. We plan to com
Slide 21: Appendices
21 Austco Healthcare Limited Appendices
Slide 22: Austco Dashboard
Austco Dashboard MAR KE T I N FO RMAT I ON* SH AR E P R I C E MOVE ME N T (12 MO NTHS) SHA RE REGISTER 2% Shares on Issue 284,188,951 27% Options on Issue 14.2M Market Cap $41.2M 52-Wk High $0.165 71% 52-Wk Low $0.087 Board and Management Current Share Price $0.145 Institutional Shareholders Retail
Slide 23: Global Market
Global Market Global nurse call market * (USDm) 2,800 2,666 We expect an outcome from COVID-19 will be the increased level of expenditure globally in the nurse call GR 2,100 CA market which would see even stronger growth rates in the 11. 3% Austco Healthcare Limited industry. Strong global demand an
Slide 24: Disclaimer
Disclaimer This presentation was prepared by Austco Healthcare Limited and was respective affiliates, associates, shareholders, directors, officers, employees, authorised for release by the Board of the Company. agents, representatives and advisers (the Austco Parties) make any representation or war
Slide 25: Clayton Astles / Brendan Maher contact details
Austco Healthcare Limited Clayton Astles CEO & Executive Director Telephone Aust: +61 411 531 170 Telephone US: +1 416 565 7457 Email: clayton.astles@austco.com Brendan Maher CFO & Company Secretary Telephone: +61 439 369 551 Email: brendan.maher@austco.com 25
Austco Healthcare — Investor Presentation (September 2021) on 6ix